On the other hand, bFGF but not VEGF has shown prognostic relevance for head and neck cancer, suggesting that the dependency of tumoral neovascularisation on angiogenic factors may vary between tumour types (Dietz et al, 2000). This evidence concerns the gene FGF2 and head and neck cancer.